Growing Clamor For Oral Contraceptive OTC Switch In UK
UK parliamentarians have added their voice to the growing calls for the MHRA to switch the daily oral contraceptive pill to OTC status. The COVID-19 pandemic has further highlighted the difficulties women face in accessing contraception, according to the politicians.
You may also be interested in...
The MHRA is consulting on two Rx-to-OTC switch applications for progestogen-only contraceptive pills containing desogestrel, one from HRA Pharma and one from Maxwellia. The move has been welcomed by UK consumer healthcare industry association, the PAGB, as well as the British Pregnancy Advisory Service.
As calls for a non-prescription daily contraceptive pill grow in the UK, switch incubator Maxwellia suggests an Rx-to-OTC reclassification of the widely-used progestogen only pill may be one of its first "switch-in-a-box" projects.
The UK's Royal College of Obstetricians and Gynaecologists joins a steadily loudening chorus of organizations calling for the prescription-to-OTC switch of oral contraceptives.